Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients.

[1]  Mélanie Schmidt,et al.  Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial , 2011, Nutrition & metabolism.

[2]  B. Nelson,et al.  A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiation. , 2011, Cancer research.

[3]  M. Cifuentes,et al.  Insulin regulates GLUT1‐mediated glucose transport in MG‐63 human osteosarcoma cells , 2011, Journal of cellular physiology.

[4]  D. Sabatini,et al.  mTORC1 controls fasting-induced ketogenesis and its modulation by ageing , 2010, Nature.

[5]  T. Wadden,et al.  Weight and Metabolic Outcomes After 2 Years on a Low-Carbohydrate Versus Low-Fat Diet , 2010, Annals of Internal Medicine.

[6]  T. Seyfried,et al.  Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse , 2010, ASN neuro.

[7]  T. Seyfried,et al.  Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report , 2010, Nutrition & metabolism.

[8]  Stephen T. C. Wong,et al.  Treating triple-negative breast cancer by a combination of rapamycin and cyclophosphamide: an in vivo bioluminescence imaging study. , 2010, European journal of cancer.

[9]  Rosa Gil,et al.  The dual PI3K/mTOR inhibitor PI‐103 promotes immunosuppression, in vivo tumor growth and increases survival of sorafenib‐treated melanoma cells , 2010, International journal of cancer.

[10]  Xiaojing Meng,et al.  Activation of the AMP-activated protein kinase-p38 MAP kinase pathway mediates apoptosis induced by conjugated linoleic acid in p53-mutant mouse mammary tumor cells. , 2010, Cellular signalling.

[11]  T. David‐Pfeuty,et al.  Targeting the cell cycle and the PI3K pathway: a possible universal strategy to reactivate innate tumor suppressor programmes in cancer cells. , 2010, International journal of oncology.

[12]  N. Navaratnam,et al.  AMPK-independent down-regulation of cFLIP and sensitization to TRAIL-induced apoptosis by AMPK activators. , 2010, Biochemical pharmacology.

[13]  Mengwei Zang,et al.  AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. , 2010, Future oncology.

[14]  R. Eckel,et al.  Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet. , 2010, The American journal of clinical nutrition.

[15]  E. Baudin,et al.  Daily Oral Everolimus Activity in Patients with Metastatic Pancreatic Neuroendocrine Tumors after Failure of Cytotoxic Chemotherapy: A Phase II Trial , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  F. G. Benedict,et al.  A biometric study of basal metabolism in man , 2010 .

[17]  K. Rau,et al.  Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation. , 2010, Journal of agricultural and food chemistry.

[18]  V. Longo,et al.  Calorie restriction and cancer prevention: metabolic and molecular mechanisms. , 2010, Trends in pharmacological sciences.

[19]  S. Devkota,et al.  A high protein moderate carbohydrate diet fed at discrete meals reduces early progression of N-methyl-N-nitrosourea-induced breast tumorigenesis in rats , 2010, Nutrition & metabolism.

[20]  Chunxiao Zhou,et al.  Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy. , 2010, Gynecologic oncology.

[21]  S. Perkins,et al.  Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. , 2010, Carcinogenesis.

[22]  T. Dorff,et al.  Fasting and cancer treatment in humans: A case series report , 2009, Aging.

[23]  Daniel B. Neill,et al.  Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3. , 2009, Carcinogenesis.

[24]  G. Powis,et al.  Inhibiting the Hypoxia Response for Cancer Therapy: The New Kid on the Block , 2009, Clinical Cancer Research.

[25]  D. Albanes,et al.  Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. , 2009, Journal of the National Cancer Institute.

[26]  M. Kiebish,et al.  Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet. , 2009, Journal of cancer research and therapeutics.

[27]  I. Tannock,et al.  Concurrent and Sequential Administration of Chemotherapy and the Mammalian Target of Rapamycin Inhibitor Temsirolimus in Human Cancer Cells and Xenografts , 2009, Clinical Cancer Research.

[28]  R. Shaw,et al.  The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.

[29]  R. Feinman,et al.  Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2 , 2009, Cancer Cell International.

[30]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[31]  G. Krissansen,et al.  Antisense hypoxia-inducible factor-1alpha augments transcatheter arterial embolization in the treatment of hepatocellular carcinomas in rats. , 2009, Human gene therapy.

[32]  D. Laub,et al.  Pretreatment with alternate day modified fast will permit higher dose and frequency of cancer chemotherapy and better cure rates. , 2009, Medical hypotheses.

[33]  David M. Sabatini,et al.  Tumours with PI3K activation are resistant to dietary restriction , 2009, Nature.

[34]  Saroj P. Mathupala,et al.  Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. , 2009, Seminars in cancer biology.

[35]  Thomas E Rohan,et al.  Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. , 2009, Journal of the National Cancer Institute.

[36]  J. Grande,et al.  Intermittent Calorie Restriction Delays Prostate Tumor Detection and Increases Survival Time in TRAMP Mice , 2006, Nutrition and cancer.

[37]  T. Seyfried,et al.  Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet , 2008, Nutrition & metabolism.

[38]  D. Leroith,et al.  The Role of Endocrine Insulin-Like Growth Factor-I and Insulin in Breast Cancer , 2008, Journal of Mammary Gland Biology and Neoplasia.

[39]  Claude Nahmias,et al.  Reproducibility of Standardized Uptake Value Measurements Determined by 18F-FDG PET in Malignant Tumors , 2008, Journal of Nuclear Medicine.

[40]  Changhan Lee,et al.  Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy , 2008, Proceedings of the National Academy of Sciences.

[41]  Robert J. Gillies,et al.  Causes and Consequences of Increased Glucose Metabolism of Cancers , 2008, Journal of Nuclear Medicine.

[42]  J. V. Nielsen,et al.  Low-carbohydrate diet in type 2 diabetes: stable improvement of bodyweight and glycemic control during 44 months follow-up , 2008, Nutrition & metabolism.

[43]  J. Sparano,et al.  The RECHARGE Trial (Reduced Carbohydrates in Resistant Aggressive Tumors). FDG-PET to monitor metastatic cancer in very low carbohydrate diet. A study to assess feasibility , 2008 .

[44]  J. Manson,et al.  A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.

[45]  S. Franceschi,et al.  Nutrient dietary patterns and the risk of breast and ovarian cancers , 2008, International journal of cancer.

[46]  J. Manson,et al.  Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. , 2007, Cancer research.

[47]  J. Sparano,et al.  Carbohydrate restriction in patients with advanced cancer: A protocol to assess safety and feasibility with an accompanying hypothesis , 2008 .

[48]  A. Johnstone,et al.  Effects of a high-protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum. , 2008, The American journal of clinical nutrition.

[49]  T. Chiles,et al.  Differential effects of energy stress on AMPK phosphorylation and apoptosis in experimental brain tumor and normal brain , 2008, Molecular Cancer.

[50]  R. Wittig,et al.  Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides , 2008, BMC Cancer.

[51]  P. Pedersen.  The cancer cell’s “power plants” as promising therapeutic targets: An overview , 2007, Journal of bioenergetics and biomembranes.

[52]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[53]  J. Lee,et al.  The Clinical Usefulness of 18-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis, Staging, and Response Evaluation After Concurrent Chemoradiotherapy for Pancreatic Cancer , 2006, Journal of clinical gastroenterology.

[54]  S. Pizzo,et al.  Is there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer? , 2006, Urology.

[55]  J. V. Nielsen,et al.  Low-carbohydrate diet in type 2 diabetes. Stable improvement of bodyweight and glycemic control during 22 months follow-up , 2006, Nutrition & metabolism.

[56]  P. Leder,et al.  Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.

[57]  Wolfgang A. Weber,et al.  Monitoring chemotherapy and radiotherapy of solid tumors , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[58]  P. Clifton,et al.  Low‐carbohydrate diets: nutritional and physiological aspects , 2006, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[59]  W. Yancy,et al.  A low-carbohydrate, ketogenic diet to treat type 2 diabetes , 2005, Nutrition & metabolism.

[60]  T. Seyfried,et al.  Targeting energy metabolism in brain cancer: review and hypothesis , 2005, Nutrition & metabolism.

[61]  J. Horowitz,et al.  Effects of dietary carbohydrate restriction with high protein intake on protein metabolism and the somatotropic axis. , 2005, The Journal of clinical endocrinology and metabolism.

[62]  Weiqin Jiang,et al.  2-Deoxyglucose as an energy restriction mimetic agent: effects on mammary carcinogenesis and on mammary tumor cell growth in vitro. , 2005, Cancer research.

[63]  N. Hwalla,et al.  Postprandial glycemic and insulinemic responses to high-carbohydrate vs high-protein meals in obese normoglycemic subjects with varied insulin sensitivity , 2005 .

[64]  M. C. Archer,et al.  Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer. , 2004, Carcinogenesis.

[65]  M. Blaufox,et al.  FDG-PET and CT characterization of adrenal lesions in cancer patients , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[66]  J. Volek,et al.  Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men. , 2004, Clinical science.

[67]  F. Nuttall,et al.  Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. , 2004, Diabetes.

[68]  W. Kraemer,et al.  Comparison of a Very Low-Carbohydrate and Low-Fat Diet on Fasting Lipids, LDL Subclasses, Insulin Resistance, and Postprandial Lipemic Responses in Overweight Women , 2004, Journal of the American College of Nutrition.

[69]  C. Townsend,et al.  Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. , 2003, Cancer research.

[70]  P. Hoskin,et al.  GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON , 2003, British Journal of Cancer.

[71]  T. Seyfried,et al.  Role of glucose and ketone bodies in the metabolic control of experimental brain cancer , 2003, British Journal of Cancer.

[72]  Kelly H. Jordan,et al.  The metabolic response of subjects with type 2 diabetes to a high-protein, weight-maintenance diet. , 2003, The Journal of clinical endocrinology and metabolism.

[73]  E. Gracely,et al.  A low-carbohydrate as compared with a low-fat diet in severe obesity. , 2003, The New England journal of medicine.

[74]  P. Dupont,et al.  Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[75]  P. Pedersen,et al.  Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. , 2002, Cancer research.

[76]  W. Kraemer,et al.  A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men. , 2002, The Journal of nutrition.

[77]  S. Shirazi-Beechey,et al.  Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy , 2002, British Journal of Cancer.

[78]  V. Diehl,et al.  Early response to chemotherapy: a surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity? , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[79]  K. Herholz,et al.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. , 1999, European journal of cancer.

[80]  P. Dupont,et al.  Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[81]  M Schwaiger,et al.  Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. , 1998, Blood.

[82]  H. Abdel-Nabi,et al.  Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. , 1998, Radiology.

[83]  T. Hickish,et al.  Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  L. Nebeling,et al.  Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. , 1995, Journal of the American College of Nutrition.

[85]  L. Jacobs,et al.  Fatty acid synthesis: a potential selective target for antineoplastic therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[86]  R. Wolfe,et al.  Carbohydrate restriction regulates the adaptive response to fasting. , 1992, The American journal of physiology.

[87]  Kazutomo Inoue,et al.  Over-expression of facilitative glucose transporter genes in human cancer. , 1990, Biochemical and biophysical research communications.

[88]  M. Tisdale,et al.  Effect of insulin on weight loss and tumour growth in a cachexia model. , 1989, British Journal of Cancer.

[89]  K. Calman,et al.  Cancer cachexia: influence of systemic ketosis on substrate levels and nitrogen metabolism. , 1988, The American journal of clinical nutrition.

[90]  R. A. Brennan,et al.  Reduction of weight loss and tumour size in a cachexia model by a high fat diet. , 1987, British Journal of Cancer.

[91]  M. Brennan,et al.  Tumoricidal potential of nutritional manipulations. , 1982, Cancer research.

[92]  A. Rofe,et al.  The inhibition of malignant cell growth by ketone bodies. , 1979, The Australian journal of experimental biology and medical science.

[93]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[94]  R. Atkins.  Dr. Atkins' New Diet Revolution , 1973 .

[95]  R. Od,et al.  The therapy of hereditary disorders of blood coagulation. , 1963 .

[96]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.